Rare Diseases

Drug Industry

Developing interactions with industry in rare diseases: lessons learned and continuing challenges

Susan A. Berry
•
Read more
Clinical Trials

Conducting an investigator-initiated randomized double-blinded intervention trial in acute decompensation of inborn errors of metabolism: Lessons from the N-Carbamylglutamate Consortium

Nicholas Ah Mew
•
Read more